Anticoagulant cessation following atrial fibrillation ablation: limits of the ECG-guided approach

References

• Wolf PA, Dawber TR, Thomas HE Jr, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28:973–977.
   PubMed Web of Science ®Google Scholar
• Gaita F, Corsinovi L, Anselmino M, et al. Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. J Am Coll Cardiol. 2013;62(21):1990–1997.
   PubMed Web of Science ®Google Scholar
• Calkins H, Kuck KH, Cappato R, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electr. 2012;33:171–257.
   PubMed Web of Science ®Google Scholar
• Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–38.
   PubMed Web of Science ®Google Scholar
• Verma A, Macle L, Cox J, et al.; CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter. Can J Cardiol. 2011;27:60–66.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014 Dec 2;64(21):e1–76.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962.
   PubMed Web of Science ®Google Scholar
• Gaita F, Sardi D, Battaglia A, et al. Incidence of cerebral thromboembolic events during long-term follow-up in patients treated with transcatheter ablation for atrial fibrillation. Europace. 2014;16:980–986.
   PubMed Web of Science ®Google Scholar
• Anselmino M, Garberoglio L, Gili S, et al. Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study. Int J Cardiol. 2017 Apr 8. [Epub ahead of print]. doi:10.1016/j.ijcard.2017.04.014
   Google Scholar
• Bunch TJ, May HT, Bair TL, et al. Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. Heart Rhythm. 2013;10:1272–1277.
   PubMed Web of Science ®Google Scholar
• Rossillo A, Bonso A, Themistoclakis S, et al. Role of anticoagulation therapy after pulmonary vein antrum isolation for atrial fibrillation treatment. J Cardiovasc Med. 2008;9:51–55.
   Google Scholar
• Themistoclakis S, Corrado A, Marchlinski FE, et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol. 2010;55:735–743.
   PubMed Web of Science ®Google Scholar
• Saad EB, d’Avila A, Costa IP, et al. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 Score ≤3: A long-term outcome study. Circ Arrhythm Electrophysiol. 2011;4:615–621.
   PubMed Web of Science ®Google Scholar
• Winkle RA, Mead RH, Engel G, et al. Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes. J Interv Card Electrophysiol. 2013;38(3):147–153.
   PubMed Web of Science ®Google Scholar
• Gray RM, Nagendran M, Maruthappu M. Is it safe to stop anticoagulants after successful surgery for atrial fibrillation? Interact Cardiovasc Thorac Surg. 2011;13:642–649.
   PubMed Web of Science ®Google Scholar
• Anselmino M, Scaglione M, Blandino A, et al. Pulmonary veins branching pattern, assessed by magnetic resonance, does not affect transcatheter atrial fibrillation ablation outcome. Acta Cardiol. 2010;65(6):665–674.
   PubMed Web of Science ®Google Scholar
• Caldwell J, Koppikar S, Barake W, et al. Prolonged P-wave duration is associated with atrial fibrillation recurrence after successful pulmonary vein isolation for paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2014;39:131–138.
   PubMed Web of Science ®Google Scholar
• Park JK, Park J, Uhm JS, et al. Low P-wave amplitude (<0.1 mV) in lead I is associated with displaced inter-atrial conduction and clinical recurrence of paroxysmal atrial fibrillation after radiofrequency catheter ablation. Europace. 2016;18:384–391.
   PubMed Web of Science ®Google Scholar
• Kizilirmak F, Demir GG, Gokdeniz T, et al. Changes in electrocardiographic P wave parameters after cryoballoon ablation and their association with atrial fibrillation recurrence. Ann Noninvasive Electrocardiol. 2016;21(6):580–587.
   PubMed Web of Science ®Google Scholar
• Proietti M, Calvieri C, Malatino L, et al. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type. Atherosclerosis. 2015 Feb;238(2):350–355.
   PubMed Web of Science ®Google Scholar
• Paciaroni M, Agnelli G, Ageno W, et al. Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention. Atherosclerosis. 2010 Oct;212(2):564–566.
   PubMed Web of Science ®Google Scholar
• Fassini G, Conti S, Moltrasio M, et al. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. 2016 Nov 11;18:1705–1710. Epub 2016 Jul 11.
   PubMed Web of Science ®Google Scholar
• Noseworthy PA, Yao X, Deshmukh AJ, et al. Patterns of anticoagulation use and cardioembolic risk after catheter ablation for atrial fibrillation. J Am Heart Assoc. 2015;4:e002597.
   PubMed Web of Science ®Google Scholar
• Blandino A, Toso E, Scaglione M, et al. Long-term efficacy and safety of two different rhythm control strategies in elderly patients with symptomatic persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(7):731–738.
   PubMed Web of Science ®Google Scholar
• Ad N, Henry L, Schlauch K, et al. The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation. Ann Thorac Surg. 2010;90:1257–1262.
   PubMed Web of Science ®Google Scholar
• Ad N, Henry L, Shuman DJ, et al. A more specific anticoagulation regimen is required for patients after the Cox-Maze procedure. Ann Thorac Surg. 2014;98:1331–1338.
   PubMed Web of Science ®Google Scholar
• Buber J, Luria D, Sternik L, et al. Left atrial contractile function following a successful modified Maze procedure at surgery and the risk for subsequent thromboembolic stroke. J Am Coll Cardiol. 2011;58:1614–1621.
   PubMed Web of Science ®Google Scholar
• Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60(6):531–538.
   PubMed Web of Science ®Google Scholar
• Anselmino M, Scaglione M, Di Biase L, et al. Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation. Heart Rhythm. 2014;11(1):2–7.
   PubMed Web of Science ®Google Scholar
• Bertaglia E, Fassini G, Anselmino M, et al. Comparison of ThermoCool® SF Catheter versus ThermoCool®Catheter in Achieving persistent electrical isolation of pulmonary veins: a pilot study. J Cardiovasc Electrophysiol. 2013;24(3):269–273.
   PubMed Web of Science ®Google Scholar
• Bisleri G, Glover B. Hybrid ablation for atrial fibrillation: current approaches and future directions. Curr Opin Cardiol. 2017 Jan;32(1):17–21.
   PubMed Web of Science ®Google Scholar